Barchart is a leading provider of market data and services to the global financial, media, and commodity industries. From our interactive charting library, through to our leading financial analysis desktops, we connect you to the content you need.
| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 17,069.0 +5.64% on 02/20/24 | | 18,040.0 -0.04% on 03/14/24 | +935.4 (+5.47%) since 02/15/24 |
| 3-Month | 16,464.0 +9.53% on 01/17/24 | | 18,040.0 -0.04% on 03/14/24 | +1,072.4 (+6.32%) since 12/15/23 |
| 52-Week | 14,836.0 +21.54% on 10/27/23 | | 18,040.0 -0.04% on 03/14/24 | +2,836.4 (+18.67%) since 03/15/23 |
Eton Pharmaceuticals acquires U.S. rights to Amglidia, approved in Europe for neonatal diabetes mellitus, aiming for 2026 FDA submission.Quiver AI SummaryEton Pharmaceuticals has acquired the U.S. rights...
Bath & Body Works reports Q3 2024 net sales of $1.6 billion, up 3%, and earnings of $0.49 per share.Quiver AI SummaryBath & Body Works, Inc. reported its third-quarter 2024 results, achieving net sales...
U-BX Technology Ltd. announced a 1-for-16 reverse stock split, effective November 27, 2024, reducing shares from 29.7 million to 1.9 million.Quiver AI SummaryU-BX Technology Ltd. announced a 1-for-16 reverse...
TransCode Therapeutics announces a 1-for-33 reverse stock split to meet Nasdaq listing requirements, effective date forthcoming.Quiver AI SummaryTransCode Therapeutics, Inc. has announced a 1-for-33 reverse...
INB-200 trial shows promising survival and immune response in glioblastoma patients, highlighting potential as innovative therapy.Quiver AI SummaryIN8bio, Inc. has reported promising results from its Phase...
Nurix Therapeutics will present updates on its drug development at the Piper Sandler Healthcare Conference on December 3, 2024.Quiver AI SummaryNurix Therapeutics, Inc. announced that its president and...
Clearside Biomedical showcased its suprachoroidal delivery technology and pipeline results at the Asia-Pacific Vitreo-Retina Society Congress.Quiver AI SummaryClearside Biomedical, Inc. announced its leadership...
Swvl Holdings Corp announces a sustainable credit facility with HSBC to finance expansion and enhance financial operations.Quiver AI SummarySwvl Holdings Corp, a technology-driven mobility solutions provider,...
NuCana reported encouraging results for NUC-7738 and NUC-3373 in recent clinical trials, with financial updates and a projected cash runway.Quiver AI SummaryNuCana plc announced encouraging Phase 2 results...
Shattuck Labs will present at two investor conferences in December 2024, focusing on its novel cancer and autoimmune disease therapeutics.Quiver AI SummaryShattuck Labs, Inc., a biotechnology company focused...
The Barchart Trading Guide is a Buy Signal with a Average Signal Strength.
| Symbol | Last | Change |
|---|---|---|
| DYH24 | 18,032.4s | +92.4 |
| DAX Index Mar '24 | ||
| DYZ24 | 19,461.0s | +103.0 |
| DAX Index | ||
| TMZ24 | 19,461.0s | +103.0 |
| Mini DAX Index | ||
| JMZ24 | 19,461.0s | +103.0 |
| Micro DAX Index | ||
| ESZ24 | 6,006.50s | +19.50 |
| S&P 500 E-Mini | ||
| NQZ24 | 20,880.25s | +30.50 |
| Nasdaq 100 E-Mini | ||
| YMZ24 | 44,826s | +431 |
| Dow Futures Mini | ||
| QRZ24 | 2,451.00s | +37.40 |
| Russell 2000 E-Mini | ||
| EWZ24 | 3,403.30s | +50.50 |
| S&P Midcap E-Mini | ||
| ETZ24 | 6,006.50s | +19.50 |
| S&P 500 Micro | ||
| NMZ24 | 20,880.25s | +30.50 |
| Nasdaq 100 Micro | ||
| VIZ24 | 15.4000 | -0.6654 |
| S&P 500 VIX | ||
| GDZ24 | 544.20 | -2.60 |
| S&P GSCI | ||
| AHZ24 | 98.17s | -0.80 |
| Bloom Commodity Index | ||
| 3rd Resistance Point | 18,199.6 |
| 2nd Resistance Point | 18,116.0 |
| 1st Resistance Point | 18,074.2 |
| Last Price | 18,032.4s |
| 1st Support Level | 17,948.8 |
| 2nd Support Level | 17,865.2 |
| 3rd Support Level | 17,823.4 |
| 52-Week High | 18,040.0 |
| Last Price | 18,032.4s |
| Fibonacci 61.8% | 16,816.1 |
| Fibonacci 50% | 16,438.0 |
| Fibonacci 38.2% | 16,059.9 |
| 52-Week Low | 14,836.0 |
